SCHEMBL13610419

SCHEMBL13610419

C(=C/c1ccccc1)\CSSSCc1ccc2nonc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
TSHR P16473 3/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
ALOX12 P18054 1/20 0.35
KMT2A Q03164 1/20 0.35
KCNJ1 P48048 1/20 0.35
KCNH2 Q12809 1/20 0.35
PKM P14618 1/20 0.35
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA2B P29275 1/20 0.34
ADORA1 P30542 1/20 0.34
DHFR P00374 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13610347 0.74 NFE2L2 (0.46) ALDH1A1MAPK1NPC1RAB9ATDP1
SCHEMBL4265198 0.74 RAB9A (0.52) NPC1RAB9ATDP1L3MBTL1
SCHEMBL13610351 0.73 ALDH1A1 (0.48) ALDH1A1TSHRALOX15MAPK1HSD17B10
SCHEMBL13610453 0.72 TDP1 (0.48) ALDH1A1TSHRALOX15MAPK1HSD17B10
SCHEMBL13610448 0.71 ALDH1A1 (0.44) ALDH1A1TSHRALOX15MAPK1HSD17B10
SCHEMBL13610449 0.71 ALDH1A1 (0.46) ALDH1A1TSHRALOX15MAPK1HSD17B10
SCHEMBL13610301 0.71 RAB9A (0.52) ALDH1A1TSHRALOX15NPC1RAB9A
SCHEMBL13610307 0.69 MAPK1 (0.48) ALDH1A1TSHRALOX15MAPK1HSD17B10
SCHEMBL13610386 0.69 EPHX1 (0.44) ALDH1A1TSHRALOX15MAPK1HSD17B10
SCHEMBL13610458 0.69 ALDH1A1 (0.42) ALDH1A1TSHRALOX15MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742635-B1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES INC (US) 2018-03-07 EP disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF TST, CTH, CBS ALDH1A1 285/4885TSHR 1867/4885ALOX15 828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.